[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/main/docs/Technology/index.md) >> Individual ID:PBN__Technology_1959 

<<<<<<< HEAD
# __Clinical trials__

## Category to which it belongs

* [Creating a resilient and adaptable environment through technology, cooperation, contact tracing, natural elements, and proper measures.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_119.md)

## Closest similar item

* [Clinical trial data](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2697.md)
* [Clinical testing](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2823.md)
* [Pragmatic trial design](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2709.md)
* [Suitable treatment and](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1863.md)
* [Improved evaluation and selection criteria for meta-analyses](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1927.md)
* [Clinical assessment](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3331.md)
* [Research on potential therapeutic options](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1960.md)
* [Research studies](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1814.md)
* [Including confirmation with clinical testing](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1358.md)
* [Drug development and testing](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2826.md)

## This technology is mentioned by

* [Current knowledge of COVID-19: Advances, challenges and future perspectives](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_118.md)

## Risks linked to this technology

* [Development of drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_431.md)
* [Expectations for vaccine](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_430.md)
=======
# __viral survival__

## Category to which it belongs

* [Advancements in molecular biology, diagnostics, vaccines, antiviral technologies, and disease surveillance for pathogen detection and control.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_223.md)

## Risks linked to this technology

* [Key factors of COVID-19 transmission](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2361.md)

## Closest similar item

* [viral enrichment](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_4481.md)
* [attenuated/inactivated virus](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_4471.md)
* [research on viral cell entry mechanisms](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_1953.md)
* [Research on viral cell entry mechanisms](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_2794.md)
* [viral testing kits](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3878.md)
* [antivirals](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_829.md)
* [antiviral](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3919.md)
* [antiviral drug research](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_838.md)
* [antiviral drugs](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_236.md)
* [separation of infected individuals from others](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3090.md)

## This Technology is identified by the following QID

* [Q7933612](https://github.com/mm80843/T3.5/blob/main/docs//Qid/Q7933612.md)
>>>>>>> refs/remotes/origin/main

